上海CMC培訓(xùn) Ensuring Drug Quality for Public Health The Implementation

上海CMC培訓(xùn) Ensuring Drug Quality for Public Health The Implementation

ID:44290610

大?。?.39 MB

頁數(shù):44頁

時間:2019-10-20

上海CMC培訓(xùn) Ensuring Drug Quality for Public Health The Implementation_第1頁
上海CMC培訓(xùn) Ensuring Drug Quality for Public Health The Implementation_第2頁
上海CMC培訓(xùn) Ensuring Drug Quality for Public Health The Implementation_第3頁
上海CMC培訓(xùn) Ensuring Drug Quality for Public Health The Implementation_第4頁
上海CMC培訓(xùn) Ensuring Drug Quality for Public Health The Implementation_第5頁
資源描述:

《上海CMC培訓(xùn) Ensuring Drug Quality for Public Health The Implementation》由會員上傳分享,免費在線閱讀,更多相關(guān)內(nèi)容在行業(yè)資料-天天文庫

1、1EnsuringDrugQualityforPublicHealthTheImplementationBrendaUratani,Ph.D.AssistantCountryDirectorFDAChinaOffice,Beijing2OverviewChallengestoGlobalizationofDrugManufacturingFDA’sWorkinChinaGMPPrinciples:Issuesofthemostconcern3ChallengesSignificantdemandin

2、resourcesforinspectionsConsequencesofglobalization,includingmoreforeignmanufacturingandclinicaltrialssitesGreatercomplexityassociatedwithmanufacturingFDAconcernaboutthestateofindustrycomplianceandinsufficientinvestmentinmanufacturingandqualitysystems4F

3、DAInternationalEffortsFDAOverseasEfforts Long-TermGoalProductscomingtotheU.S.meetU.S.requirements.StrengthenedRegulatoryCounterpartsIndustryResponsibility:SupplyChainManagementatPointofManufacture,PointofExport,andWhenPresentedforImportation5FDAOversea

4、sPresence CurrentLocationsChinaIndiaLatinAmericaEuropeMiddleEast(2010)6FDA’sWorkinChina78FDAChinaOfficeIn-CountryStaffBeijingChrisHickey,OfficeDirectorMikeKravchuk,Deputy(device)BrendaUratani(drug)IreneChan(food)ShanghaiCharlesAhn(druginspection)BJMarc

5、iante(deviceinspection)GuangzhouDennisDoupnik(foodinspection)DennisHudson(foodinspection)FDA/SFDAAgreement:KeyProvisionsKeyProvisions:RegistrationofdesignateddrugsanddevicesJointTraining/CapacityBuildingGreater/MoreRapidInformationSharingGreaterAccesst

6、oFacilitiesProductIntegrity/Anti-counterfeitingStrengthenedFDA,SFDACollaborationUnderMultilateralAuspices9DrugsinChina:WhatHasFDADone?FDA-SFDACollaborationInspectionsEngagementofIndustryCapacity-Building10WhatIsChinaDoing?UpdatingStandards,MethodsRevis

7、ionofChinaCGMPWorkingtoImproveDrugAdverseEventReportingTrainingEliteGroupofInspectorsRe:InternationalStandardsAttemptingtoStrengthenDrugApplicationReviewProcessTakingMoreActiveRoleinInternationalStandard-SettingShiftingFocustoConductMorePre-ApprovalIns

8、pectionsUtilizingToolstoDetectCounterfeitingSupplyChain:DevelopingToolsandStandardsforTracking/Tracing11China’sRoleinDrugDevelopment:ChallengesforChinaNeedforRegulatoryReformUniformityofimplementationofCGMPacrossallprovincesRegulatoryAu

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁,下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動畫的文件,查看預(yù)覽時可能會顯示錯亂或異常,文件下載后無此問題,請放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫負責(zé)整理代發(fā)布。如果您對本文檔版權(quán)有爭議請及時聯(lián)系客服。
3. 下載前請仔細閱讀文檔內(nèi)容,確認文檔內(nèi)容符合您的需求后進行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時可能由于網(wǎng)絡(luò)波動等原因無法下載或下載錯誤,付費完成后未能成功下載的用戶請聯(lián)系客服處理。